mRNA-Based Gene Editing Therapeutics
Genome editing has been gaining importance since the last decade as a potential alternative to gene therapy. Nucleases (ZFNs, TALENs, etc.) and the CRISPR–Cas9 system provide powerful tools for site-specific modification of genomes. However, these approaches have the risk of nonspecific editing as the DNA-based vectors translate the enzymes involved. In-vitro transcribed mRNA (IVT mRNA) […]
Horizon Scan for Opportunities in Women’s Health Products
A leading company manufacturing women’s healthcare products on a large scale contacted Stellarix for a horizon scan to identify emerging opportunities in the women’s health products sector. The study focused on uncovering trends and innovations in women’s health, evaluating market potential, and highlighting key areas of growth. Client Background The client is a global player […]
Comparator Drugs: A Critical Element in Clinical Research
Comparator drugs are of significant importance in clinical research. Based on pharmaceutical comparator studies and blind comparator stability testing, a drug product’s similarity or superiority to a commercial drug product in the same therapeutic class can be determined.With rising diseases, pharmaceutical companies are under pressure to develop strong strategies for choosing a comparator drug and […]
Carbon Credits: Profitable Avenue for Life Sciences
The growing global interest in sustainability and environmental responsibility has created new financial gateways for mainly every industry worldwide. Life science companies, usually dealing with pharmaceuticals, biotechnological, and medical devices, have recently found yet another way to get involved in environmental activities that will contribute to their environmental bottom line while not neglecting their revenue […]
Partner Scouting: Integrated Solutions for Hypertension Management
A renowned company dealing in healthcare technology engaged with Stellarix for partner scouting, identifying potential vendors for software and hardware solutions. The client sought technology that could help patients suffering from cardiovascular issues. It requested planning to select CROs (Contract Research Organizations) and sponsors to extend their clinical research. The findings helped the client make […]
Landscape: Child Resistant Packaging
A startup engaged with Stellarix to learn more about the child-resistant (CR) packaging market, technological advancement, size, trends, and regulations of the landscape. It requested that the CR packaging segment be explored, as well as emerging innovations and major players participating in the sector. The study provided the client with important insights that helped the […]
Technology Scouting: Emerging Technologies for Drug Traceability
A top pharmaceutical company contacted Stellarix to learn more about technological advancements like smart sensors and artificial intelligence in the industry to enhance drug traceability. The client wanted to delve into regulatory compliance, reliability, and pharma tracking and grasp an edge over competitors with accuracy and operational efficiencies, offering cost-effectiveness, safety, and leadership. Client Background […]
Wearable Technology In Healthcare: Benefits, Challenges, Types
Wearable technology in healthcare has experienced a remarkable surge in popularity in recent years. Embodied within this surge lies the astounding progress made in biosensor technology, resulting in heightened precision and accuracy. Moreover, the continuous advancements in battery technology have led to the development of compact sizes, enabling seamless integration into wearable medical devices. Such […]
Patient Twinning: The Future of MedTech
Here’s a typical caregiving scene: a patient comes in for medical treatment for recovery and healing. The clear goal is to achieve wholesome healing for the individual from his previous state of disease and illness. Doctors, physicians, and hospital teams intervene with medicines and treatment processes, aiming at the best possible health outcome for the patient. […]
Pricing Analysis of a New Drug
A biopharma industry leader with potential candidates in a phase III trial for neurological and cardiovascular diseases was interested in making a pricing decision. The engagement included understanding competitor drug positioning along with efficacy study analysis to provide better insights on price points for clients. Client Background: The client is one of the key players […]